Abstract
Tuberculosis (TB) is the first cause of death from infectious diseases worldwide. Only a single anti-TB vaccine is currently available for clinical use, but its efficacy is not achieved with certainty. The aim of this work is to provide a basis for the rational design of a neo-glycoconjugate vaccine against TB. Structural characterization of recombinant antigenic proteins from Mycobacterium tuberculosis (MTB) Ag85B (rAg85B, variants, and semi-synthetic glycoconjugates) was initially carried out. Identification of antibody epitope analyses by proteolytic affinity-mass spectrometry and surface plasmon resonance (SPR) biosensor analyses were performed in order to qualitatively identify and quantitatively characterize interaction structures of the antigens with antibodies from different sources. A commercial monoclonal antibody and polyclonal antibodies from different sources (patients with active TB, vaccinated individuals, and a healthy control) were employed to analyze antigen-antibody interactions. These combined approaches provided the identification of different assembled epitope regions on the recombinant MTB antigens, their affinity binding constants in the interactions with specific antibodies, and revealed the importance of protection from excessive glycosylation. The identified epitope peptides should constitute a suitable basis for the design of new specific target vaccines.
Similar content being viewed by others
References
World Health Organization. Global tuberculosis report 2017. Geneva: WHO Press; 2017.
Ahmad TA, Eweida AE, Sheweita SA. B-cell epitope mapping for the design of vaccines and effective diagnostics. Trials Vaccinol. 2016;5:71–83.
He L, Zhu J. Computational tools for epitope vaccine design and evaluation. Curr Opin Virol. 2015;11:103–12.
Opuni KFM, Al-Majdoub M, Yefremova Y, El-Kased RF, Koy C, Glocker MO. Mass spectrometric epitope mapping. Mass Spectrom Rev. 2018;37(2):229–41.
Macht M, Fiedler W, Kürzinger K, Przybylski M. Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T. Biochemistry. 1996;35(49):15633–9.
McLaurin J, Cecal R, Kierstead ME, Tian X, Phinney AL, Manea M, et al. Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis. Nat Med. 2002;8(11):1263–9.
Stefanescu R, Iacob RE, Damoc EN, Marquardt A, Amstalden E, Manea M, et al. Mass spectrometric approaches for elucidation of antigen-antibody recognition structures. Eur J Mass Spectrom. 2007;13(1):69–75.
Juszczyk P, Paraschiv G, Szymanska A, Kolodziejczyk AS, Rodziewicz-Motowidlo S, Grzonka Z, et al. Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with β-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation. J Med Chem. 2009;52(8):2420–8.
Moise A, André S, Eggers F, Krzeminski M, Przybylski M, Gabius HJ. Toward bioinspired galectin mimetics: identification of ligand-contacting peptides by proteolytic-excision mass spectrometry. J Am Chem Soc. 2011;133(38):14844–7.
Petre BA, Ulrich M, Stumbaum M, Bernevic B, Moise A, Döring G, et al. When is mass spectrometry combined with affinity approaches essential? A case study of tyrosine nitration in proteins. J Am Soc Mass Spectrom. 2012;23(11):1831–40.
Iurascu MI, Marroquin Belaunzanar O, Cozma C, Petrausch U, Renner C, Przybylski M. An HLA-B27 homodimer specific antibody recognizes a discontinuous mixed-disulfide epitope as identified by affinity-mass spectrometry. J Am Soc Mass Spectrom. 2016;27(6):1105–12.
Moise A, Maeser S, Rawer S, Eggers F, Murphy M, Bornheim J, et al. Substrate and substrate-mimetic chaperone binding sites in human α-galactosidase a revealed by affinity-mass spectrometry. J Am Soc Mass Spectrom. 2016;27(6):1071–8.
Conroy PJ, Ayyar BV, Byrne B, O'Kennedy R. Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends. Expert Rev Vaccines. 2010;9(6):645–64.
Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev. 2011;35(6):1126–57.
Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol. 2012;7:353–84.
Demkow U, Białas-Chromiec B, Filewska M, Sobiecka M, Kuś J, Szturmowicz M, et al. Humoral immune response against mycobacterial antigens in bronchoalveolar fluid from tuberculosis patients. J Physiol Pharmacol. 2005;56(4):79–84.
Temporini C, Bavaro T, Tengattini S, Serra I, Marrubini G, Calleri E, et al. Liquid chromatography-mass spectrometry structural characterization of neo glycoproteins aiding the rational design and synthesis of a novel glycovaccine for protection against tuberculosis. J Chromatogr A. 2014;1367:57–67.
Piubelli L, Campa M, Temporini C, Binda E, Mangione F, Amicosante M, et al. Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins. Microb Cell Factories. 2013;12:115.
Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev. 1992;56(4):648–61.
Kadir NA, Sarmiento ME, Acosta A, Norazmi MN. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice. Int J Mycobacteriol. 2016;5(1):7–13.
Bavaro T, Tengattini S, Piubelli L, Mangione F, Bernardini R, Monzillo V, et al. Glycosylation of recombinant antigenic proteins from Mycobacterium tuberculosis: in silico prediction of protein epitopes and ex vivo biological evaluation of new semi-synthetic glycoconjugates. Molecules. 2017;22(7):1081.
Bavaro T, Filice M, Temporini C, Tengattini S, Serra I, Morelli CF, et al. Chemoenzymatic synthesis of neoglycoproteins driven by the assessment of protein surface reactivity. RSC Adv. 2014;4:56455–65.
Rinaldi F, Tengattini S, Calleri E, Bavaro T, Piubelli L, Pollegioni L, et al. Application of a rapid HILIC-UV method for synthesis optimization and stability studies of immunogenic neo-glycoconjugates. J Pharm Biomed Anal. 2017;144:252–62.
Tengattini S, Domínguez-Vega E, Temporini C, Bavaro T, Rinaldi F, Piubelli L, et al. Hydrophilic interaction liquid chromatography-mass spectrometry as a new tool for the characterization of intact semi-synthetic glycoproteins. Anal Chim Acta. 2017;981:94–105.
Rinaldi F, Tengattini S, Piubelli L, Bernardini R, Mangione F, Bavaro T, et al. Rational design, preparation and characterization of recombinant Ag85B variants and their glycoconjugates with T-cell antigenic activity against Mycobacterium tuberculosis. RSC Adv. 2018;8:23171–80.
Bavaro T, Piubelli L, Amicosante M, Terreni M. From new diagnostic targets to recombinant proteins and semi-synthetic protein-based vaccines. Curr Org Chem. 2016;20(11):1150–68.
ZipTip sample clean-up. In: Proteomics & Mass Spectrometry Protocols. Donald Danforth Plant Science Center. https://www.danforthcenter.org/docs/default-source/CoreFacilities/pmsf/ziptip-protocol.pdf?sfvrsn=2.
Strohalm M, Hassman M, Kosata B, Kodícek M. mMass data miner: an open source alternative for mass spectrometric data analysis. Rapid Commun Mass Spectrom. 2008;22(6):905–8.
Huygen K. The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis. Front Immunol. 2014;5:321.
Kashyap RS, Shekhawat SD, Nayak AR, Purohit HJ, Taori GM, Daginawala HF. Diagnosis of tuberculosis infection based on synthetic peptides from Mycobacterium tuberculosis antigen 85 complex. Clin Neurol Neurosurg. 2013;115(6):678–83.
Shen G, Behera D, Bhalla M, Nadas A, Laal S. Peptide-based antibody detection for tuberculosis diagnosis. Clin Vaccine Immunol. 2009;16(1):49–54.
Nahtman T, Jernberg A, Mahdavifar S, Zerweck J, Schutkowski M, Maeurer M, et al. Validation of peptide epitope microarray experiments and extraction of quality data. J Immunol Methods. 2007;328(1–2):1–13.
Lee BY, Horwitz MA. T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred Guinea pigs. Infect Immun. 1999;67(5):2665–70.
Zhang F, Lu X, Guo N, Zhang Y, Ji P, Hu J, et al. The prediction of T- and B-combined epitope of Ag85B antigen of Mycobacterium tuberculosis. Int J Clin Exp Med. 2016;9(2):1408–21.
Dewi IP. B-cell epitope prediction of Mycobacterium tuberculosis Ag85A antigen. UNEJ e-Proceeding. 2017;S.l.:108–111.
Acknowledgments
The research visiting stay of Francesca Rinaldi at the Steinbeis Centre for Biopolymer Analysis and Biomedical Mass Spectrometry, Rüsselsheim am Main, was supported by an increase of the PhD scholarship and a grant for international mobility from the University of Pavia.
We dedicate this paper to the memory of Prof. Massimo Amicosante, who made a substantial contribution sharing his knowledge and providing valuable suggestions with great humanity and professionalism.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Antibody samples were blind analyzed and derived from anonymous patients belonging to a no profit Biobank located at University of Rome “Tor Vergata”.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 1196 kb)
Rights and permissions
About this article
Cite this article
Rinaldi, F., Lupu, L., Rusche, H. et al. Epitope and affinity determination of recombinant Mycobacterium tuberculosis Ag85B antigen towards anti-Ag85 antibodies using proteolytic affinity-mass spectrometry and biosensor analysis. Anal Bioanal Chem 411, 439–448 (2019). https://doi.org/10.1007/s00216-018-1466-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-018-1466-z